
Carl D Regillo, MD, FACS, begins the discussion highlighting each disease state and the landscape of treatment.
Experts discuss the latest treatments for neovascular AMD, DME, and RVO, highlighting key efficacy and safety trial data along with case examples.

Carl D Regillo, MD, FACS, begins the discussion highlighting each disease state and the landscape of treatment.

Margaret A Chang, MD, MS, discusses efficacy and safety results of faricimab for neovascular age-related macular degeneration (nAMD) treatments.

Dante J Pieramici, MD, shifts the conversation to diabetic macular edema (DME) and the promising drying and anatomical results from an open-label long-term extension trial.

John W Kitchens, MD, bookends the discussion by highlighting the landscape of branch vein occlusion (BRVO) treatment options.